{"id":"W1891914108","doi":"10.2147/dddt.s84177","title":"Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analogues","year":2015,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":208,"is_retracted":false,"has_abstract":true,"ca_institutions":"Foothills Medical Centre","funders":"American Society of Clinical Oncology","keywords":"Pasireotide; Octreotide; Medicine; Gastroenterology; Internal medicine; Somatostatin; Adverse effect; Neuroendocrine tumors; Carcinoid syndrome; Refractory (planetary science); Acromegaly; Hormone","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00288281,0.001235731,0.003025295,0.0003505891,0.0004071651,0.0008711212,0.0009147375,0.001456135,0.002081267],"category_scores_gemma":[0.001468123,0.000612088,0.00175379,0.0003770151,0.001034779,0.00088383,0.0002629692,0.002659124,0.0005972252],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005962992,"about_ca_system_score_gemma":0.001673991,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007631308,"about_ca_topic_score_gemma":0.001614527,"domain_scores_codex":[0.9993643,0.0003677705,0.0000354041,0.0000874742,0.00005041343,0.00009467015],"domain_scores_gemma":[0.9988661,0.0003046737,0.000161215,0.00009983173,0.00008122937,0.0004870403],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8938539,0.03474438,0.002341419,0.0007437527,0.00141902,0.0002230435,0.0001959242,0.001552319,0.02387063,0.0003045945,0.00163251,0.03911851],"study_design_scores_gemma":[0.8022869,0.1929907,0.001937036,0.00001876513,0.0002256382,0.00009308082,0.0000253653,0.0007444907,0.0009053321,0.0001097156,0.0006493511,0.00001362141],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9878461,0.003628982,0.001410886,0.0006085832,0.0003157383,0.004363862,0.0005923244,0.0001059169,0.001127695],"genre_scores_gemma":[0.983648,0.002418352,0.003296118,0.001392493,0.0003403209,0.005870611,0.001352092,0.00003801585,0.001644082],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003025295,"threshold_uncertainty_score":0.01524591,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04525629135987289,"score_gpt":0.3048283482362036,"score_spread":0.2595720568763307,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}